Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 1/2 1

Status

Suspended 2Completed 2Unknown 1Terminated 1Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Neoplasms 1330Breast Neoplasms 686Carcinoma, Non-Small-Cell Lung 543Neoplasm Metastasis 436Lymphoma 435Leukemia, Myeloid, Acute 432Melanoma 402Prostatic Neoplasms 380Multiple Myeloma 364Lymphoma, Non-Hodgkin 355Ovarian Neoplasms 343Colorectal Neoplasms 333Precursor Cell Lymphoblastic Leukemia-Lymphoma 328Pancreatic Neoplasms 328Leukemia, Lymphocytic, Chronic, B-Cell 323Leukemia 282Lung Neoplasms 275Glioblastoma 266Unspecified Adult Solid Tumor, Protocol Specific 257Recurrence 252Lymphoma, Follicular 248Lymphoma, Large B-Cell, Diffuse 245Brain Neoplasms 232Lymphoma, Mantle-Cell 210Carcinoma, Renal Cell 193Hodgkin Disease 192Head and Neck Neoplasms 192Myelodysplastic Syndromes 187Burkitt Lymphoma 172Glioma 171

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Completed × Advanced Refractory Solid Tumors × Clear all
NCT03349073 2022-11-18

An Extension Study for T-1101 (Tosylate) to Treat Advanced Refractory Solid Tumors

Taivex Therapeutics Corporation

Phase 1 Completed
3 enrolled
Other solid neoplasm

Advanced Refractory Solid Tumors

NCT04324372 2022-08-12

Clinical Study of HEC68498 in Patients With Advanced Refractory Solid Tumors

Sunshine Lake Pharma Co., Ltd.

Phase 1 Completed
12 enrolled
Other solid neoplasm

Advanced Refractory Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡